Crossbow Therapeutics vs Signadori Bio
Crossbow Therapeutics vs Signadori Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Crossbow Therapeutics is on 55/100 and Signadori Bio on 45/100.
Where each one leads
Crossbow Therapeutics
- our overall score: 55/100 against 45/100
- agent readiness: 45/100 against 40/100
- domain rating: 25/100 against 6/100
- funding raised: $157M against $12.2M
Signadori Bio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Crossbow Therapeutics | Signadori Bio |
|---|---|---|
| What it is | Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes. | Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors. |
| Category | Biotechnology, Pharmaceuticals, Cancer, Immunotherapy | Biotechnology, Pharmaceuticals, Oncology, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2021 | 2025 |
| Headquarters | Cambridge, United States | Paris, France |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Crossbow Therapeutics | Signadori Bio |
|---|---|---|
| Employees | 40 | Not published |
| Total funding | $157M | $12.2M |
| Latest round | Series B | Seed Extension |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Crossbow Therapeutics | Signadori Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 45/100 |
| Traction | 56/100 | 35/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 15/100 | 16/100 |
| Quality | 65/100 | 50/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (45/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 6/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Crossbow Therapeutics | Signadori Bio |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Wix | Lovable |
| Open source | Yes | No |
Crossbow Therapeutics vs Signadori Bio: common questions
Which is better, Crossbow Therapeutics or Signadori Bio?
On our 0-100 score Crossbow Therapeutics rates higher (55/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Crossbow Therapeutics and Signadori Bio compare on the numbers?
Crossbow Therapeutics leads on our overall score (55/100 against 45/100), agent readiness (45/100 against 40/100), domain rating (25/100 against 6/100), funding raised ($157M against $12.2M).
Read the full Crossbow Therapeutics review and pricing or the Signadori Bio review and pricing. You can also browse other Crossbow Therapeutics alternatives we track.